Ended soon
Swiss healthcare company Roche has unveiled its new digital medical algorithm suite called navify Algorithm Suite, which is aimed at aiding earlier diagnosis of cancer and other medical conditions. The platform was introduced at the HIMSS Global Conference in Chicago, USA, and complies with GDPR regulations in Europe as well as HIPAA in the USA. The platform offers labs and hospitals one platform to connect easily to digital medical algorithms from a diverse range of innovators. Simultaneously, navify Algorithm Suite also offers universities and other providers of digital algorithms a direct channel to distribute their proven innovations to practising physicians in markets worldwide.
The navify Algorithm Suite aims to optimise care and increase early diagnosis by offering evidence-based decision-making tools to physicians in the diagnosis, treatment, and monitoring of patients. The platform is designed to be embedded in existing healthcare workflows and information systems for optimal information security management. Roche believes that as healthcare data is set to grow, digital medical algorithms can generate actionable insights that physicians can use to deliver personalised healthcare.
The first algorithms in the suite focus on oncology, specifically a pre-screening algorithm to identify at-risk healthy people for colorectal cancer and an algorithm intended to aid in the diagnosis of early stage Hepatocellular Carcinoma (HCC) in patients with chronic liver disease. Additional algorithms for oncology, cardiology, and other diseases, such as lung and infectious diseases, are already in the pipeline. The navify Algorithm Suite is currently available in Europe and Asia-Pacific.
According to Moritz Hartmann, Global Head of Roche Information Solutions at Roche Diagnostics, the platform enables clinicians to easily order the medical algorithms they need from Roche and other providers to get enhanced insights that improve patient care. Roche is committed to providing personalised healthcare and believes that digital medical algorithms will play a significant role in helping physicians to provide high-quality patient care.
Roche’s new digital medical algorithm suite demonstrates the potential of healthcare technology to transform patient care. By providing clinicians with access to a diverse range of digital medical algorithms, Roche aims to improve early diagnosis and optimise patient care. With additional algorithms for oncology, cardiology, and other diseases in the pipeline, the navify Algorithm Suite is set to become an essential tool for physicians worldwide.
